← Back to Search

Anti-inflammatory agent

AMT-101 (Dose A) for Pouchitis (FILLMORE Trial)

Phase 2
Waitlist Available
Research Sponsored by Applied Molecular Transport
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• Chronic or recurrent pouchitis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

FILLMORE Trial Summary

This study is evaluating whether a drug called AMT-101 may help treat chronic antibiotic-resistant pouchitis.

FILLMORE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

FILLMORE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Histologic Healing
Stool Frequency Response
Secondary outcome measures
Change in Endoscopic Score
Change in Stool Frequency
Histologic Response

FILLMORE Trial Design

2Treatment groups
Active Control
Group I: AMT-101 (Dose A)Active Control1 Intervention
Dose A: AMT-101 Tablet
Group II: AMT-101 (Dose B)Active Control1 Intervention
Dose B: AMT-101 Tablet

Find a Location

Who is running the clinical trial?

Applied Molecular TransportLead Sponsor
4 Previous Clinical Trials
258 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis
2021. "Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04741087.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top